Will OpenAI or Anthropic IPO first?

**Stage 1 — Blind analysis (ignore market price):**

- *Signal landscape.* The clearest, concrete near‑term signal in the supplied information is the media report that OpenAI is targeting a public listing as early as September 2026, with a >$1T valuation cited. There is no comparable, recent public report that Anthropic has targeted a near‑term IPO. That asymmetry in publicly reported intent is the single strongest piece of evidence favoring OpenAI as the first to market.

- *Incentives and runway.* OpenAI has much stronger and clearer commercial pathways (large revenue contracts, deep Microsoft strategic alignment, broad enterprise deployments) that create both the operational readiness and investor pressure/liquidity demand to pursue an IPO earlier. Anthropic, while well funded, has historically been quieter about public markets and may prefer private fundraising or alternative liquidity events to preserve control or product direction.

- *Structural hurdles.* OpenAI faces nontrivial governance and regulatory complications (complex cap structure and governance commitments, heavy scrutiny around safety and potential national‑security implications). Those hurdles are real and can delay an IPO — but they are not proof of indefinite delay. The firm’s unique governance could be resolved through pre‑IPO restructuring or carefully designed prospectus disclosures.

- *Countervailing possibilities.* Anthropic could accelerate if it needs capital or if it judges that a lighter regulatory profile and simpler capitalization make a cleaner, faster IPO. Also, press reports can be wrong or targets can slip: a September 2026 target is an intention, not a hard deadline.

- *Judgement and probability.* Given the asymmetric information (OpenAI has the only concrete near‑term signal), stronger commercial incentives to list, and Anthropic’s lack of announced timing, I estimate a high likelihood that OpenAI will IPO before Anthropic. Reasoning to a numeric value: treat the reported target as a meaningful posterior boost (opening a window where OpenAI can legally and operationally file well before Anthropic), but discount for potential regulatory delays, execution slippage and the chance Anthropic surprises. This leads to an independent probability of 78% that OpenAI will be the first of the two to IPO.

**Stage 2 — Market calibration (compare to current market price):**

- *Market price observed:* Yes = 0.25, No = 0.75. Under my working assumption that Yes = OpenAI first, the market currently assigns only 25% to OpenAI beating Anthropic to an IPO.

- *Why the market might be low relative to my view.* Several explanations could justify a low market price even if the underlying signal favors OpenAI: - *Regulatory and governance risk priced heavily.* Market participants may overweight the chance that OpenAI’s unique governance, security reviews, or complex Microsoft ties will materially delay or prevent a 2026 filing — even enough to allow Anthropic to move first. If traders believe regulatory delay is likely and long, that reduces OpenAI’s implied lead. - *Skepticism about the reporting.* The market may treat the September 2026 report as weak/noisy sourcing (single article, no S-1 or confirmed schedule), and thus discount it heavily. - *Anthropic acceleration risk.* Some traders may believe Anthropic is more likely to execute a quicker, simpler IPO (smaller size, cleaner cap table) and therefore could outpace OpenAI even if OpenAI publicly signals a target. - *Ambiguity in contract wording or how the market defines the event.* If some traders interpret the question differently (for example, interpreting 'IPO first' as 'any public listing, including a spinout or direct listing' or mapping Yes/No to the opposite company), prices could reflect that confusion rather than a pure belief about OpenAI vs Anthropic timing.

- *My calibration / trading implication.* Given the asymmetric reported intent and OpenAI’s stronger near‑term commercial incentives, the market price of 25% looks materially lower than my independent estimate. That suggests either: (a) the market is mispricing OpenAI’s probability, or (b) traders are correctly pricing high regulatory/structural delay risk that I am underweight. If the mapping of Yes/No is as I assume, this is a potential mispricing opportunity; if mapping is reversed, the market may be more reasonable. Because of uncertainty in the report and regulatory tail risks, I recommend a conviction‑weighted view rather than an all‑in assertion.